Diastolic Dysfunction in Individuals With Human Immunodeficiency Virus Infection: Literature Review, Rationale and Design of the Characterizing Heart Function on Antiretroviral Therapy (CHART) Study.
暂无分享,去创建一个
K. Anstrom | E. Braunwald | R. Kim | J. Butler | A. Kalogeropoulos | Adrian F. Hernandez | R. Scherzer | E. Velazquez | P. Hsue | P. Desvigne‐Nickens | Svati H. Shah | S. Shah | S. Shah | S. J. Shah | Sanjiv J. Shah
[1] M. Lederman,et al. Prospective Analysis of Lipid Composition Changes with Antiretroviral Therapy and Immune Activation in Persons Living with HIV , 2017, Pathogens & immunity.
[2] Sanjiv J. Shah,et al. Clinical characteristics of HIV-infected patients with adjudicated heart failure , 2017, European journal of preventive cardiology.
[3] Kaleab Z. Abebe,et al. Temporal Relation Between Myocardial Fibrosis and Heart Failure With Preserved Ejection Fraction: Association With Baseline Disease Severity and Subsequent Outcome , 2017, JAMA cardiology.
[4] Olga V. Patterson,et al. Association Between HIV Infection and the Risk of Heart Failure With Reduced Ejection Fraction and Preserved Ejection Fraction in the Antiretroviral Therapy Era: Results From the Veterans Aging Cohort Study , 2017, JAMA cardiology.
[5] Sanjiv J. Shah,et al. A Test in Context: E/A and E/e' to Assess Diastolic Dysfunction and LV Filling Pressure. , 2017, Journal of the American College of Cardiology.
[6] Patrizio Lancellotti,et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2016, European heart journal cardiovascular Imaging.
[7] Michael T. Lu,et al. Subclinical myocyte injury, fibrosis and strain in relationship to coronary plaque in asymptomatic HIV-infected individuals , 2016, AIDS.
[8] M. Egger,et al. Trends in life expectancy of HIV-positive adults on antiretroviral therapy across the globe: comparisons with general population , 2016, Current opinion in HIV and AIDS.
[9] Eike Nagel,et al. T1 Mapping in Characterizing Myocardial Disease: A Comprehensive Review. , 2016, Circulation research.
[10] J. Todd,et al. Short-term and long-term cardiovascular risk, metabolic syndrome and HIV in Tanzania , 2016, Heart.
[11] D. Douek,et al. Gut barrier structure, mucosal immunity and intestinal microbiota in the pathogenesis and treatment of HIV infection , 2016, AIDS Research and Therapy.
[12] A. Kengne,et al. A Meta-Analysis of the Metabolic Syndrome Prevalence in the Global HIV-Infected Population , 2016, PloS one.
[13] J. Gieseke,et al. Cardiac Magnetic Resonance Reveals Signs of Subclinical Myocardial Inflammation in Asymptomatic HIV-Infected Patients , 2016, Circulation. Cardiovascular imaging.
[14] J. Ananworanich,et al. Immune activation during acute HIV infection and the impact of early antiretroviral therapy , 2016, Current opinion in HIV and AIDS.
[15] S. Piechnik,et al. HIV-1–Related Cardiovascular Disease Is Associated With Chronic Inflammation, Frequent Pericardial Effusions, and Probable Myocardial Edema , 2016, Circulation. Cardiovascular imaging.
[16] M. Budoff,et al. Non-Classical Monocytes and Monocyte Chemoattractant Protein-1 (MCP-1) Correlate with Coronary Artery Calcium Progression in Chronically HIV-1 Infected Adults on Stable Antiretroviral Therapy , 2016, PloS one.
[17] G. Bloomfield,et al. The Causes of HIV-Associated Cardiomyopathy: A Tale of Two Worlds , 2016, BioMed research international.
[18] Sanjiv J. Shah,et al. Prognostic Importance of Impaired Systolic Function in Heart Failure With Preserved Ejection Fraction and the Impact of Spironolactone , 2015, Circulation.
[19] Jeffrey N. Martin,et al. Novel Biomarkers of Cardiac Stress, Cardiovascular Dysfunction, and Outcomes in HIV-Infected Individuals. , 2015, JACC. Heart failure.
[20] T. Hallett,et al. Future challenges for clinical care of an ageing population infected with HIV: a modelling study , 2015, The Lancet. Infectious diseases.
[21] D. Bluemke,et al. Abnormal Myocardial Function Is Related to Myocardial Steatosis and Diffuse Myocardial Fibrosis in HIV-Infected Adults. , 2015, The Journal of infectious diseases.
[22] A. Bayés‐Genís,et al. Structural heart disease and ST2: cross-sectional and longitudinal associations with echocardiography. , 2015, The American journal of cardiology.
[23] M. Gladwin,et al. Elevated NT-Pro-Brain Natriuretic Peptide Level Is Independently Associated with All-Cause Mortality in HIV-Infected Women in the Early and Recent HAART Eras in the Women’s Interagency HIV Study Cohort , 2015, PloS one.
[24] D. Dey,et al. Increased pericardial fat accumulation is associated with increased intramyocardial lipid content and duration of highly active antiretroviral therapy exposure in patients infected with human immunodeficiency virus: a 3T cardiovascular magnetic resonance feasibility study , 2015, Journal of Cardiovascular Magnetic Resonance.
[25] A. Leite-Moreira,et al. HIV Patients Have Impaired Diastolic Function that is Not Aggravated by Anti-Retroviral Treatment , 2015, Cardiovascular Drugs and Therapy.
[26] G. Pedrizzetti,et al. Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging. , 2015, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[27] S. Solomon,et al. Left Atrium in Heart Failure With Preserved Ejection Fraction: Structure, Function, and Significance , 2014, Circulation. Heart failure.
[28] V. Ortiz de la Tabla,et al. Coinfection with Human Herpesvirus 8 Is Associated with Persistent Inflammation and Immune Activation in Virologically Suppressed HIV-Infected Patients , 2014, PloS one.
[29] D. Duprez,et al. Severity of Cardiovascular Disease Outcomes Among Patients With HIV Is Related to Markers of Inflammation and Coagulation , 2014, Journal of the American Heart Association.
[30] A. Huang,et al. Prospective echocardiographic assessment of cardiac structure and function in Chinese persons living with HIV. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[31] J. Butler,et al. Heart Failure in Patients With Human Immunodeficiency Virus Infection: Epidemiology, Pathophysiology, Treatment, and Future Research , 2014, Circulation.
[32] Y. Izumiya,et al. Growth differentiation factor-15 is a useful prognostic marker in patients with heart failure with preserved ejection fraction. , 2014, The Canadian journal of cardiology.
[33] Milton Packer,et al. Impaired systolic function by strain imaging in heart failure with preserved ejection fraction. , 2014, Journal of the American College of Cardiology.
[34] M. Essop,et al. HIV protease inhibitors and onset of cardiovascular diseases: a central role for oxidative stress and dysregulation of the ubiquitin-proteasome system. , 2014, Biochimica et biophysica acta.
[35] S. Piechnik,et al. Comprehensive Cardiac Magnetic Resonance Imaging and Spectroscopy Reveal a High Burden of Myocardial Disease in HIV Patients , 2013, Circulation.
[36] W. Paulus,et al. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. , 2013, Journal of the American College of Cardiology.
[37] H. Ullum,et al. Persisting Inflammation and Chronic Immune Activation but Intact Cognitive Function in HIV-Infected Patients After Long-Term Treatment With Combination Antiretroviral Therapy , 2013, Journal of acquired immune deficiency syndromes.
[38] M. Obokata,et al. Incremental diagnostic value of la strain with leg lifts in heart failure with preserved ejection fraction. , 2013, JACC. Cardiovascular imaging.
[39] H. Ullum,et al. Persistent Inflammation and Endothelial Activation in HIV-1 Infected Patients after 12 Years of Antiretroviral Therapy , 2013, PloS one.
[40] F. Gaita,et al. Cardiac dysfunction in pauci symptomatic human immunodeficiency virus patients: a meta-analysis in the highly active antiretroviral therapy era. , 2013, European heart journal.
[41] D. Margolis,et al. Antiretroviral Therapy Initiated During Acute HIV Infection Fails to Prevent Persistent T-Cell Activation , 2013, Journal of acquired immune deficiency syndromes.
[42] David S. Wishart,et al. HMDB 3.0—The Human Metabolome Database in 2013 , 2012, Nucleic Acids Res..
[43] W. W. Tang,et al. Prognostic value of cardiac troponin in chronic stable heart failure: a systematic review , 2012, Heart.
[44] P. Kellman,et al. Association Between Extracellular Matrix Expansion Quantified by Cardiovascular Magnetic Resonance and Short-Term Mortality , 2012, Circulation.
[45] S. Abbara,et al. Arterial inflammation in patients with HIV. , 2012, JAMA.
[46] E. Rosenberg,et al. Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients. , 2011, The Journal of infectious diseases.
[47] V. Roger,et al. Progression of left ventricular diastolic dysfunction and risk of heart failure. , 2011, JAMA.
[48] James D. Thomas,et al. Mortality rate in patients with diastolic dysfunction and normal systolic function. , 2011, Archives of internal medicine.
[49] W. Kop,et al. Prognostic utility of ST2 in patients with acute dyspnea and preserved left ventricular ejection fraction. , 2011, Clinical chemistry.
[50] L. Kuller,et al. N-terminal-proB-type natriuretic peptide predicts cardiovascular disease events in HIV-infected patients , 2011, AIDS.
[51] O. Beran,et al. Antiretroviral treatment of HIV infection does not influence HIV-specific immunity but has an impact on non-specific immune activation. , 2011, Current HIV research.
[52] J. Gottdiener,et al. High Prevalence of Echocardiographic Abnormalities among HIV-infected Persons in the Era of Highly Active Antiretroviral Therapy. , 2011, Clinical Infectious Diseases.
[53] Stefan Neubauer,et al. Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold , 2010, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[54] R. Nishimura,et al. Exercise Hemodynamics Enhance Diagnosis of Early Heart Failure With Preserved Ejection Fraction , 2010, Circulation. Heart failure.
[55] Geoffrey S Ginsburg,et al. Association of a Peripheral Blood Metabolic Profile With Coronary Artery Disease and Risk of Subsequent Cardiovascular Events , 2010, Circulation. Cardiovascular genetics.
[56] Jeffrey N. Martin,et al. Impact of HIV Infection on Diastolic Function and Left Ventricular Mass , 2010, Circulation. Heart failure.
[57] O. Fiehn,et al. FiehnLib: mass spectral and retention index libraries for metabolomics based on quadrupole and time-of-flight gas chromatography/mass spectrometry. , 2009, Analytical chemistry.
[58] P. Massip,et al. HIV-1 Residual Viremia Correlates with Persistent T-Cell Activation in Poor Immunological Responders to Combination Antiretroviral Therapy , 2009, PloS one.
[59] G. McComsey,et al. Relationship between inflammatory markers, endothelial activation markers, and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapy. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[60] B. Fevang,et al. Homeostatic chemokines CCL19 and CCL21 promote inflammation in human immunodeficiency virus‐infected patients with ongoing viral replication , 2009, Clinical and experimental immunology.
[61] D. J. Veldhuisen,et al. Galectin‐3: a novel mediator of heart failure development and progression , 2009, European journal of heart failure.
[62] A. Cohen,et al. Subclinical cardiac abnormalities in human immunodeficiency virus-infected men receiving antiretroviral therapy. , 2008, The American journal of cardiology.
[63] Vilmundur Gudnason,et al. Long-Term Interleukin-6 Levels and Subsequent Risk of Coronary Heart Disease: Two New Prospective Studies and a Systematic Review , 2008, PLoS medicine.
[64] D. Bluemke,et al. Arterial Stiffness Is Associated With Regional Ventricular Systolic and Diastolic Dysfunction: The Multi-Ethnic Study of Atherosclerosis , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[65] W. Abhayaratna,et al. Characteristics of left ventricular diastolic dysfunction in the community: an echocardiographic survey , 2006, Heart.
[66] T. Marwick,et al. Relation of arterial stiffness to diastolic dysfunction in hypertensive heart disease , 2005, Heart.
[67] J. Schaper,et al. Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression. , 2004, Journal of the American College of Cardiology.
[68] K. Bailey,et al. Plasma Brain Natriuretic Peptide to Detect Preclinical Ventricular Systolic or Diastolic Dysfunction: A Community-Based Study , 2004, Circulation.
[69] G. Baxter. The natriuretic peptides , 2004, Basic Research in Cardiology.
[70] H. Hense,et al. Prevalence of left ventricular diastolic dysfunction in the community. Results from a Doppler echocardiographic-based survey of a population sample. , 2003, European heart journal.
[71] K. Dingemans,et al. Cardiomyopathy with mitochondrial damage associated with nucleoside reverse-transcriptase inhibitors. , 2002, The New England journal of medicine.
[72] James B Seward,et al. Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. , 2002, Journal of the American College of Cardiology.
[73] R. Kronmal,et al. Multi-Ethnic Study of Atherosclerosis: objectives and design. , 2002, American journal of epidemiology.
[74] G. d’Ettorre,et al. Matrix Metalloproteinase-9 and Tissue Inhibitors of Matrix Metalloproteinase-1 in Plasma of Patients Co-Infected with HCV and HIV , 2002, HIV clinical trials.
[75] Y. Benjamini,et al. Controlling the false discovery rate in behavior genetics research , 2001, Behavioural Brain Research.
[76] S. Stein,et al. Deconvolution gas chromatography/mass spectrometry of urinary organic acids--potential for pattern recognition and automated identification of metabolic disorders. , 1999, Rapid communications in mass spectrometry : RCM.
[77] J. Smeitink,et al. Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway , 1998, AIDS.